S11 Ep20: FDA Approval Insights: Perioperative Durvalumab for Resectable NSCLC

OncLive® On Air - A podcast by OncLive® On Air

Podcast artwork

Drs Patel and Stiles discuss the significance of the FDA approval of perioperative durvalumab for patients with resectable non–small cell lung cancer.